They need a few practical guardrails consistent hydration, a protein anchor, smaller-but-regular eating, and a realistic expectation that the first weeks of dose changes can feel off. This guide shows the simplest levers that reliably help
About SURPASS-4 and the SURPASS clinical trial program SURPASS-4 (NCT03730662) is a 52-week, randomized, parallel, open-label trial comparing the efficacy and safety of tirzepatide 5 mg, 10 mg and 15 mg to insulin glargine in adults with type 2 diabetes inadequately controlled with at least one and up to three oral antihyperglycemic medications (metformin, sulfonylureas or SGLT-2 inhibitors), who have increased cardiovascular (CV) risk
Among the 12 different bioactive compounds, four bioactive compoundsnamely, hexadecanoic acid, methyl tetradecanoate, ethoxy-disilane, and 9,12-octadecadienoic acidwere found to be potent enough and can be used for in vivo studies (122)
Efficient Prior Authorization Support : Our team ensures streamlined insurance processes, handling everything from start to finish
The USP standard (0.9% benzyl alcohol, sterile, non-pyrogenic) is what every published trial protocol uses
